Prostate Cancer - Results from #25240

Prostate cancer pathology audits: Is central pathology review still warranted? - Abstract August 2, 2012

Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer - Abstract August 2, 2012

[18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy: Influence of antiandrogen therapy - A preliminary study - Abstract August 2, 2012

Lycopene, tomato products, and prostate cancer incidence: A review and reassessment in the PSA screening era - Abstract August 2, 2012

Cabazitaxel for prostate cancer: Patient preparation and ongoing care - Abstract August 2, 2012

Prostate cancer overview. Part 1: Non-metastatic disease - Abstract August 2, 2012

Implication of high grade intraepithelial neoplasia in adverse pathology after radical prostatectomy - Abstract August 2, 2012

Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer - Abstract August 2, 2012

Pharmacokinetic/Pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer - Abstract August 2, 2012

Masculinity beliefs predict psychosocial functioning in african american prostate cancer survivors - Abstract August 2, 2012

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer - Abstract August 2, 2012

The current status of active surveillance for prostate cancer - Abstract August 2, 2012

Management of prostate cancer patients with lymph node involvement: A rapidly evolving paradigm - Abstract August 1, 2012

Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients - Abstract August 1, 2012

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer - Abstract August 1, 2012

Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy - Abstract August 1, 2012

NIH State-of-the-Science Conference: Role of active surveillance in the management of men with localized prostate cancer August 1, 2012

Efficacy and safety of denosumab for the treatment of bone metastases in patients with advanced cancer - Abstract August 1, 2012

Bone micro-environment in prostate cancer: impact, treatment and implications for nursing practice - Abstract August 1, 2012

Beyond prostate-specific antigen - Future biomarkers for the early detection and management of prostate cancer - Abstract August 1, 2012

Page 1263 of 1435